lifestyle.forkstofeet.com

Rapport Therapeutics to Announce Topline Results for RAP-219 Phase 2a Trial in Focal Onset Seizures on Monday, September 8, 2025

Written by

Rapport Therapeutics to Announce Topline Results for RAP-219 Phase 2a Trial in Focal Onset Seizures on Monday, September 8, 2025 – NEWSnet – News… as it used to be

More Press Releases

April 22, 2026

Dreame to Host DREAME NEXT Launch Event in San Francisco, Unveiling Next Decade of Tech

April 22, 2026

Animal health and nutrition company releases inaugural ESG report on Earth Day

April 22, 2026

Voltus Carbon Response Program Earns 2026 Environment+Energy Leader Award

April 22, 2026

AriseAlpha Launches AI Trading Bot with Automated Crypto & Stock Portfolio Strategies in 2026